Mode
Text Size
Log in / Sign up
N/A N=4,322 Health Services Research

Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System

Breast Cancer · Colorectal Cancer

Enrolled (actual)
4,322
Serious AEs
6.2%
Results posted
Mar 2024
Primary outcome: Primary: Proportion of Complex Cancer Survivors Meeting Quality of Care Guidelines for Chronic Conditions and Follow-up Cancer Surveillance

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Care Coordination Strategies (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Texas Southwestern Medical Center
Primary completion
Apr 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Proportion of Complex Cancer Survivors Meeting Quality of Care Guidelines for Chronic Conditions and Follow-up Cancer Surveillance
PRIMARY
Patient Perception of Care (Scale)
11.4; 11.2; 10.8

Summary

Nearly 70% of people living with cancer are "complex patients" with multiple chronic conditions who must deal not only with effects of their cancer but also continuing diseases such as diabetes, depression, hypertension, or heart disease. Care coordination strategies shown to be effective in improving outcomes for common medical conditions seen in primary care include: systematic transitions for patients to and from specialty care; intensive case management; and a team-based approach to comprehensive care. Despite an Institute of Medicine report suggesting these strategies as potential ways to improve care for cancer survivors, their implementation has not yet been evaluated for cancer survivors. Parkland Health and Hospital Systems will be implementing care coordinator strategies as part of as quality assurance/quality improvement activities, which Aim 2 and Aim 3 (research components) will evaluate. This protocol has been organized to reflect this distinction between the aims. The investigators expect no more than 1500 patients to be included in these study aims.

Eligibility Criteria

Inclusion Criteria

  • Adult patients over 18 years of age;
  • AND diagnosed with Stage I-III incident breast or colorectal cancers;
  • AND with one or more of the following highly prevalent ambulatory-sensitive chronic conditions (diabetes, hypertension, chronic lung disease, chronic kidney disease, depression, or heart disease).

Exclusion Criteria

  • Patients with in situ cancers (Stage 0) and those with metastatic disease (Stage IV);
  • OR Patients with impaired hearing or speech;
  • OR Inability to speak English or Spanish.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02943265). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search